Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
11.66
+0.12 (1.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Indivior Employees
Indivior had 1,164 employees as of December 31, 2023. The number of employees increased by 236 or 25.43% compared to the previous year.
Employees
1,164
Change (1Y)
236
Growth (1Y)
25.43%
Revenue / Employee
$1,015,464
Profits / Employee
-$2,577
Market Cap
1.45B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Teladoc Health | 5,600 |
| Evotec SE | 5,061 |
| AtriCure | 1,200 |
| InMode | 581 |
| BioCryst Pharmaceuticals | 536 |
| Immunocore Holdings | 497 |
| Travere Therapeutics | 380 |
| RxSight | 374 |
INDV News
- 4 weeks ago - Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024 - PRNewsWire
- 6 weeks ago - Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior - PRNewsWire
- 7 weeks ago - Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month - PRNewsWire
- 2 months ago - Indivior PLC (INDV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Indivior Announces Q3 2024 Financial Results - PRNewsWire
- 2 months ago - Indivior: This Value Stock Has Over 100% Upside Potential If Market Share Stabilizes In 2025 - Seeking Alpha
- 2 months ago - British drugmaker Indivior cuts 2024 revenue forecast, shares fall - Reuters
- 2 months ago - Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion - PRNewsWire